PubMed Health⌕ Search

PubMed · 10510534

[Hemodiafiltration].

Abstract

Haemodiafiltration (HDF) is renal replacement therapy. It is a method of blood clearance based on the principle of diffuse and convection transport of substances through a semipermeable membrane. The method uses high-flux membranes, usually synthetic ones with a high ultrafiltration coefficient. According to the principle of preparation of a substitution solution HDF is divided into bag methods (substitution solutions in bags), on-line HDF (continual preparation of substitution solution in an apparatus in the course of the procedure) and HDF based on reversed filtration of the dialyzation solution through the membrane of the haemodiafilter. Depending on the length and frequency of the procedure, there is intermittent HDF used in particular in the treatment of chronic renal failure and continual HDF used in acute conditions where renal failure is part of multiorgan dysfunction. Depending on the site of administration of the substitution solution, we differentiate between predilution HDF (the substitution solution is administered into the blood stream before haemodiafiltration) and postdilution HDF (the substitution solution is administered into the bloodstream after the haemodiafilter). HDF methods are highly effective in the elimination of low-molecular and medium-molecular substances. They are effective and well tolerated by patients. They can be used under conditions when standard haemodialysis is associated with circulatory instability or is not sufficiently effective. The author describes principles and possibilities of application of different modifications of HDF methods.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Eiselt. 1999-03-29. [Hemodiafiltration].. https://pubmed.ncbi.nlm.nih.gov/10510534/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Practical approaches to management of hyperphosphatemia: can we improve the current situation?

Despite advanced technology and regular and efficient dialysis treatment, the prevalence of hyperphosphatemia still is unacceptably high. Nevertheless, a neutral phosphorus balance level can generally be achieved by optimization of dialysis prescription in combination with individualized dietary and medical strategies. Besides increasing the fraction of inorganic phosphate (iP) removed by convection through the application of hemodiafiltration, extension of daily or weekly treatment time is the most promising way to neutralize phosphorus balance. Dietary phosphate restriction, the second corner stone of phosphate management, bears the risk of development of protein malnutrition. Phosphate binders (PBs) effectively reduce intestinal iP absorption, but are mostly dosed inadequately in relation to meal phosphorus content. Phosphate management may be substantially improved by enabling patients to self-adjust the PB dose to individual meal phosphate content, similar to self-adjusting insulin dose to carbohydrate intake by diabetics. A recently developed Phosphate Education Program (PEP) provides simple training tools to instruct patients to eye-estimate meal phosphorus content based on newly defined phosphorus units instead of milligrams. PEP is the first approach applying the concept of patient empowerment in the management of hyperphosphatemia in dialysis patients.

Hemodiafiltration↗